HCK is overexpressed in Waldenstrom macroglobulinemia (WM) and other hematological malignancies and is targeted by Ibrutinib for the induction of apoptosis in chronic lymphocytic leukemia [37, 38]. This evidence concerns the gene HCK and Waldenstrom macroglobulinemia.